Spinal fluid clues may predict Post-Birth depression
NCT ID NCT06947278
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 200 women having planned C-sections to see if levels of a brain protein called BDNF in their spinal fluid and blood could predict postpartum depression. Researchers measured BDNF before surgery and checked for depression symptoms up to 42 days after birth. The goal was to find a way to identify at-risk mothers early, but this was an observational study, not a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
200 people
The number who actually took part.
- Started
-
May 2025
- Finished
-
Nov 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients undergoing elective cesarean section under combined lumbar-rigid anesthesia in the First People's Hospital of Lianyungang City
- Ages
-
20 to 35 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Meet the indications for cesarean section and have no contraindications to neuraxial anesthesia; 2. 20 years old≤ age ≤ 35 years old; 3. 37≤ gestational age\< 42; 4. American Society of Anesthesiologists (ASA) grade II\~III; 5. singleton pregnancy; 6. Voluntarily participate in this study and sign the informed consent form. Exclusion Criteria: 1. Unable to understand the content of the questionnaire correctly; 2. a clear history of mental illness, depression, cognitive impairment and other diseases; 3. Patients who have been taking sedative, analgesic and psychotropic drugs for a long time; 4. Those who have recently used glucocorticoids or immunosuppressants; 5. Those who are allergic to or have contraindications to any of the drugs used in this study; 6. Serious pregnancy complications, such as preeclampsia, placental hyperplasia, etc.; 7. Participated in other clinical studies within the last 3 months.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Postpartum depression (PPD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Affiliated Lianyungang Hospital of Xuzhou Medical University
Lianyungang, Jiangsu, 222000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a pill ease severe postpartum depression?
- Could more doula visits ease postpartum depression?
- A healing hand: could Doula-Midwife teams transform postpartum recovery for NICU moms?
- Magnetic pulses to the brain: a Drug-Free hope for peripartum depression?
- Can a wearable light device lift the fog of postpartum depression?
- Can a Three-Day pill ease postpartum depression?